DiamiR Biosciences Corp | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,989 results for “DiamiR Biosciences Corp”

Trials

View all 5249 →

Chiron Corp HCV E1/E2 Vaccine

60 participants · First posted Jul 13, 2007

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

24 participants · First posted Sep 19, 2008

Prospective Observational Clinical Follow-up of Euromi Biosciences Pre-filled Silicone Gel Breast Implants

177 participants · First posted Aug 14, 2023

Drugs

View all 1059 →

MediPhage MRPA(AmpliPhi Biosciences Corp.)

Glucocerebrosidase gene therapy(AmpliPhi Biosciences Corp.)

tgAAV-CF gene therapy(AmpliPhi Biosciences Corp.)

Organizations

View all 645 →

AURA BIOSCIENCES

India

Assembly Biosciences

United States

EUROMI BIOSCIENCES

France

News

View all 2036 →

Aptorum Group and DiamiR Biosciences Advance Merger, Launch Alzheimer's Biomarker Collaboration with AlzLabs

Aptorum Group and DiamiR Biosciences Publish Breakthrough Study on Blood-Based Glioblastoma Detection Using microRNA Biomarkers

BriaCell Therapeutics Reports Progress in Phase 3 Metastatic Breast Cancer Trial

Page 1 of 899